US Stock MarketDetailed Quotes
IOVA Iovance Biotherapeutics
Watchlist
6.640
+0.380+6.07% Close 12/04 16:00 ET
6.6400.0000.00%
Pre 04:00 ET
6.650High6.200Low5.94MVolume
6.270Open6.260Pre Close38.67MTurnover2.80%Turnover RatioLossP/E (TTM)1.70BMarket Cap9.36052wk HighLossP/E (Static)255.92MShares3.21052wk Low2.52P/B1.41BFloat Cap165.000Historical High--Dividend TTM212.00MShs Float1.000Historical Low--Div YieldTTM7.19%Amplitude6.512Avg Price1Lot Size
About Iovance Biotherapeutics Company
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007, and is headquartered in San Carlos, CA.
Company Profile
SymbolIOVA
Company NameIovance Biotherapeutics
Listing Date02/26/2015
Founded2007
CEOMr. Frederick G. Vogt, J.D.,PhD
MarketNASDAQ
Employees503
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address825 Industrial Road,Suite 400,4th Floor
CitySan Carlos
ProvinceCalifornia
CountryUnited States of America
Zip Code94070
Phone1-650-260-7120
Websitehttp://www.iovance.com
Company Executives
- Name
- Position
- Salary
- Frederick G. Vogt, J.D.,PhD
- General Counsel, Interim Chief Executive Officer and President
- 5.26M
- Dr. Igor P. Bilinsky, PhD
- Chief Operating Officer
- 2.08M
- Jean-Marc Bellemin
- Chief Financial Officer and Principal Accounting Officer
- 2.19M
- Dr. Friedrich Graf Finckenstein
- Chief Medical Officer
- 2.21M
- Dr. Iain D. Dukes, D.Phil.
- Chairman of the Board
- 932.50K
- General Merrill A. McPeak
- Independent Director
- 489.99K
- Wendy L. Yarno
- Independent Director
- --
- Dr. Michael Weiser,M.D.,PhD
- Independent Director
- 737.49K
- Ryan D. Maynard
- Independent Director
- 482.49K
- Dr. Athena Countouriotis, M.D.
- Independent Director
- 482.49K
- Wayne Rothbaum
- Independent Director
- 240.00K
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--